Product Image

PectaClear

4.7
★ ★ ★ ★ ★
(284 ratings)
Sodium 120 mg
Potassium 130 mg
Product Image
Score58
A specialized pectin-and-alginate product with incidental mineral content. It is poorly suited to heart support, potassium supplementation, or exercise hydration.
How scoring works
Capsule
Quantity:180 Capsule(s) • (60 servings)
Goals:

Score 58

A specialized pectin-and-alginate product with incidental mineral content. It is poorly suited to heart support, potassium supplementation, or exercise hydration.
How scoring works
$99.31($1.65 per serving)
iHerb
$ 109.25
Vitacost
$ 109.25
Pure Formulas
$ 99.31
Vitacost
$ 109.25
Report prices

Analysis

The six-capsule serving centers on 1.5 g of modified citrus pectin and 750 mg of modified alginate. Its 130 mg potassium and 120 mg sodium amounts are secondary to that binding-focused design.

The mineral forms are not identified, limiting assessment of their quality. Neither amount is sufficient for substantial electrolyte replacement, and the formula does not provide broad cardiovascular actives.

It only makes sense for someone deliberately seeking this pectin-and-alginate combination. Buyers seeking potassium, hydration, or heart support can find more direct and economical formulas.

Who is it for
  • Adults specifically seeking modified citrus pectin with alginate
  • Users who do not need meaningful electrolyte replacement
  • People comfortable with a six-capsule serving
Best for
  • A focused pectin-and-alginate formula
  • Users prioritizing specialty ingredients over minerals
  • People who understand its limited heart relevance

Pros

  • Clearly states the pectin and alginate amounts
  • Provides a focused specialty formula
  • Includes modest potassium and sodium

Cons

  • Mineral forms are not identified
  • Potassium and sodium amounts are too low for electrolyte use
  • Six capsules provide weak mineral value

Nutrient quality

64 Moderate impact

The actives are identifiable and do not appear aggressively dosed. A low pectin amount and uncertain fit with heart support substantially weaken the profile.

.

Ingredient transparency

67 High impact

Total amounts for the branded actives are visible. Their composition, non-active ingredients, and full usage directions remain unclear.

.

Customer satisfaction

64 Moderate impact

The supplied average rating is very strong. No specific review comments were supplied, so repeated negative experiences cannot be assessed.

.

Value for money

32 Situational impact

The formula supplies identifiable actives but little dose value. Premium pricing and uncertain differentiation make it poorly competitive.

.
Report analysis

Ingredients

IngredientAmount per serving
Total Carbohydrates
2 Gram(s)
Sodium
120 mg
Potassium
130 mg
PectaSol-C (Citrus Pectin, Modified)
1.5 Gram(s)
Algimate (Alginate Complex, Modified)
750 mg
Gluten Free Adults 18–50 Vegan Vegetarian
Report overview
Sodium · 120 mg OverallScore57
D- Active Ingredient Quality & BioavailabilityC+ Dose, Safety & Label TransparencyB- Value

The sodium amount is too low for exercise hydration, and the sodium and potassium forms are not identified. Modified citrus pectin and alginate dominate the formula, so the minerals are incidental rather than performance-focused. A higher serving cost is partly tied to those specialty ingredients, but electrolyte value remains limited.

Potassium · 130 mg OverallScore34
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The stated 130 mg potassium amount comes from a citrus-pectin product rather than a purpose-built mineral formula. Its exact chemical form is unknown, and the label provides only one value without a compound-to-elemental breakdown. A relatively high serving cost makes it inefficient for users seeking potassium rather than pectin.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  2. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  3. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  4. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.
    Behers BJ; Behers BM; Stephenson-Moe CA; Vargas IA; Meng Z; Thompson AJ; Melchor J; Wojtas CN; Rosario MA; Baker JF; Deevers AC; Mouratidis RW; Sweeney MJ · Nutrients · 2024
    Meta-analysisHeart Health forPotassium
  5. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  6. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium
  7. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  8. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  9. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  10. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Vardeny O; Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Matsumoto S; Merkely B; Zieroth S; Yilmaz MB; Lay-Flurrie J; Viswanathan P; Horvat-Broecker A; Scalise A; McMurray JJV; Solomon SD · JAMA cardiology · 2025
    Randomized trial6,001 participantsHeart Health forPotassium